In this we evaluated the predictive significance of TXR1 overexpression/TSP1 downregulation, together with BRCA1 mRNA expression, in samples from patients with all histologies of NSCLC treated with either docetaxel/gemcitabine or docetaxel/cisplatin combinations. The gene discussed is PRR13; the disease is non-small cell lung carcinoma.